Cargando…

The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure

BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Wang, Zhao, Wang, Jiaxi, Lv, Hairong, Xiao, Xia, Lu, Wenyi, Jin, Xin, Meng, Juanxia, Pu, Yedi, Zhao, MingFeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273631/
https://www.ncbi.nlm.nih.gov/pubmed/35837537
http://dx.doi.org/10.2147/IDR.S364525
_version_ 1784745118433017856
author Zhang, Meng
Wang, Zhao
Wang, Jiaxi
Lv, Hairong
Xiao, Xia
Lu, Wenyi
Jin, Xin
Meng, Juanxia
Pu, Yedi
Zhao, MingFeng
author_facet Zhang, Meng
Wang, Zhao
Wang, Jiaxi
Lv, Hairong
Xiao, Xia
Lu, Wenyi
Jin, Xin
Meng, Juanxia
Pu, Yedi
Zhao, MingFeng
author_sort Zhang, Meng
collection PubMed
description BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remains to be studied, especially after empiric antibiotic treatment. METHODS: We retrospectively analyzed the differences between mNGS and the traditional methods in 192 patients with hematological malignancies who have received empiric antibiotic treatment. Samples were collected when patient had chills or half an hour before peak body temperature. And we compared the differences between FN and non-FN patients, mainly including types of pathogens and the diagnostic value of different pathogens. RESULTS: Despite receiving empirical treatment, the pathogen detection rate of mNGS was significantly higher than the traditional method (80.21% vs 25.00%, P<0.001). And it has obvious advantages in detecting mixed pathogens infection (80.21% vs 4.17%, P<0.001). Then, we found that mNGS saw more pathogens in the FN than in the non-FN group, especially fungus. 21/33 (63.63%) of FN patients was diagnosed with fungal infections. The fungal detection rate in FN was significantly higher than non-FN group (32.35% vs 12.22%, P=0.001). Besides, the sensitivity of mNGS was higher than the traditional methods in both FN and non-FN group (P<0.001), but no significant difference in specificity (P>0.05). In the FN group, empiric antibiotic treatment of 46/102 (45.10%) patients did not treat all the pathogens detected by mNGS. After adjusting the antimicrobial regimen according to the results of mNGS, the effective rate at 72 hours and 7 days was 22/46 (47.83%) and 24/102 (52.17%), respectively. CONCLUSION: mNGS had a significant impact on the diagnosis of infection and the second-line antimicrobial therapy in FN. mNGS plays a more important role in FN patients, especially in the diagnosis of fungal infections. PURPOSE: Firstly, we compared the difference between mNGS and the traditional methods in the diagnosis of infection. Secondly, we assessed the value of mNGS in FN patients by comparing it with non-FN patients, including types of pathogens and the diagnostic value of different pathogens. In order to show that mNGS plays a more important role in FN.
format Online
Article
Text
id pubmed-9273631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92736312022-07-13 The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure Zhang, Meng Wang, Zhao Wang, Jiaxi Lv, Hairong Xiao, Xia Lu, Wenyi Jin, Xin Meng, Juanxia Pu, Yedi Zhao, MingFeng Infect Drug Resist Original Research BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remains to be studied, especially after empiric antibiotic treatment. METHODS: We retrospectively analyzed the differences between mNGS and the traditional methods in 192 patients with hematological malignancies who have received empiric antibiotic treatment. Samples were collected when patient had chills or half an hour before peak body temperature. And we compared the differences between FN and non-FN patients, mainly including types of pathogens and the diagnostic value of different pathogens. RESULTS: Despite receiving empirical treatment, the pathogen detection rate of mNGS was significantly higher than the traditional method (80.21% vs 25.00%, P<0.001). And it has obvious advantages in detecting mixed pathogens infection (80.21% vs 4.17%, P<0.001). Then, we found that mNGS saw more pathogens in the FN than in the non-FN group, especially fungus. 21/33 (63.63%) of FN patients was diagnosed with fungal infections. The fungal detection rate in FN was significantly higher than non-FN group (32.35% vs 12.22%, P=0.001). Besides, the sensitivity of mNGS was higher than the traditional methods in both FN and non-FN group (P<0.001), but no significant difference in specificity (P>0.05). In the FN group, empiric antibiotic treatment of 46/102 (45.10%) patients did not treat all the pathogens detected by mNGS. After adjusting the antimicrobial regimen according to the results of mNGS, the effective rate at 72 hours and 7 days was 22/46 (47.83%) and 24/102 (52.17%), respectively. CONCLUSION: mNGS had a significant impact on the diagnosis of infection and the second-line antimicrobial therapy in FN. mNGS plays a more important role in FN patients, especially in the diagnosis of fungal infections. PURPOSE: Firstly, we compared the difference between mNGS and the traditional methods in the diagnosis of infection. Secondly, we assessed the value of mNGS in FN patients by comparing it with non-FN patients, including types of pathogens and the diagnostic value of different pathogens. In order to show that mNGS plays a more important role in FN. Dove 2022-07-07 /pmc/articles/PMC9273631/ /pubmed/35837537 http://dx.doi.org/10.2147/IDR.S364525 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Meng
Wang, Zhao
Wang, Jiaxi
Lv, Hairong
Xiao, Xia
Lu, Wenyi
Jin, Xin
Meng, Juanxia
Pu, Yedi
Zhao, MingFeng
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title_full The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title_fullStr The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title_full_unstemmed The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title_short The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
title_sort value of metagenomic next-generation sequencing in hematological malignancy patients with febrile neutropenia after empiric antibiotic treatment failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273631/
https://www.ncbi.nlm.nih.gov/pubmed/35837537
http://dx.doi.org/10.2147/IDR.S364525
work_keys_str_mv AT zhangmeng thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT wangzhao thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT wangjiaxi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT lvhairong thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT xiaoxia thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT luwenyi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT jinxin thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT mengjuanxia thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT puyedi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT zhaomingfeng thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT zhangmeng valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT wangzhao valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT wangjiaxi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT lvhairong valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT xiaoxia valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT luwenyi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT jinxin valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT mengjuanxia valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT puyedi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure
AT zhaomingfeng valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure